Five Prime

First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
CP Wire
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
Mon, 10/1/18 - 09:38 am
Five Prime
Zai Lab
bemarituzumab
gastric cancer
GSK Exclusively Licenses Intellectual Property for Respiratory Disease Target Identified Using Five Prime’s Proprietary Protein Discovery Platform
Yahoo
Thu, 07/14/16 - 07:14 pm
GSK
R&D
Five Prime
drug discovery
Respiratory
Five Prime Therapeutics Announces Updated Data in Mesothelioma Patients from Ongoing Phase 1b Trial of FP-1039 Presented at 2016 ASCO Annual Meeting
Yahoo
Sat, 06/4/16 - 06:27 pm
Five Prime
ASCO 2016
mesothelioma
FP-1039
3 Small Biotechs That Look Very Healthy
TheStreet.com
Fri, 05/27/16 - 10:56 pm
PDL Biopharma
Five Prime
Anika Therapeutics
4 Biotech Stocks You Should Be Watching Right Now
TheStreet.com
Fri, 04/22/16 - 09:08 pm
Five Prime
Inovio
Medivation
Ocular Therapeutix
GlaxoSmithKline dumps Five Prime's cancer drug in the midst of Phase I
Fierce Biotech
Sat, 03/12/16 - 09:42 am
GSK
Five Prime
clinical trials
mesothelioma
Five Prime Therapeutics Receives FDA Orphan Drug Designation for FPA008 in Pigmented Villonodular Synovitis (PVNS)
Yahoo
Wed, 01/13/16 - 09:57 am
Five Prime
FDA
orphan drugs
FPA008
PVNS
Bristol-Myers, Five Prime enter licensing deal of up to $1.74 bln
Yahoo/Reuters
Thu, 10/15/15 - 08:44 am
Bristol-Myers Squibb
Five Prime
FPA008
cancer immunotherapy
Bluebird Bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
Yahoo
Tue, 05/26/15 - 04:23 pm
Bluebird Bio
Five Prime
R&D
chimeric antigen receptor T-cell immunotherapies
Five Prime gets $30M upfront from Bristol-Myers and will study combination cancer treatment
Yahoo/AP
Mon, 11/24/14 - 06:03 pm
Five Prime
Bristol-Myers Squibb
Opdivo
FPA008
melanoma
Five Prime Therapeutics' Novel Target Licensed by Glaxo
Yahoo/Zacks.com
Wed, 09/17/14 - 05:08 pm
Five Prime
GSK
Bristol Myers Deal Overshadows Q4 loss at Five Prime
Yahoo/Zacks.com
Thu, 03/27/14 - 10:48 am
earnings
Bristol-Myers Squibb
Five Prime
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Mon, 03/17/14 - 10:53 am
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
3 Biotech Stocks Spiking on Big Volume
TheStreet.com
Thu, 03/13/14 - 08:31 am
WuXi PharmaTech
NewLink Genetics
Five Prime
Five Prime Therapeutics: A Small Cap With A Big Protein Therapeutic Platform
Seeking Alpha
Sat, 01/11/14 - 07:57 am
Five Prime
protein therapeutics
Five Prime Therapeutics - Another Risky Cancer Research Public Offering
Seeking Alpha
Mon, 09/23/13 - 09:38 am
Five Prime
IPOs
cancer
IPO Preview: Five Prime Therapeutics
Seeking Alpha
Tue, 09/17/13 - 06:06 pm
IPOs
Five Prime
GlaxoSmithKline licenses potential muscle disorder drugs from Five Prime in $139M deal
Yahoo/AP
Wed, 08/4/10 - 07:42 am
GSK
licensing
Five Prime